• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR Back to Search Results
Catalog Number CDS0601-XTR
Device Problems Off-Label Use (1494); Failure to Advance (2524)
Patient Problems Tissue Damage (2104); Tricuspid Regurgitation (2112)
Event Date 08/28/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).The customer reported the device was discarded.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This is being filed to report during the procedure tissue damage occurred.It was reported that this was a mitraclip procedure to treat tricuspid regurgitation (tr) with grade of 3+.The clip delivery system (cds) was advanced without issue; however, there was not enough height as the physician was unable to get a perpendicular trajectory through the valve because the distance was too short.It was difficult to position the clip, so the clip could not be implanted.The cds and clip were removed.A small chordae tear was noted during the procedure.Although, there was no clip entanglement, the chordae tear was likely from the device/procedure as it was not present pre-procedure.The procedure was aborted, tr remained at 3+.No additional information was provided.
 
Manufacturer Narrative
Exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents reported from this lot.It should be noted as per the mitraclip ntr/xtr instructions for use (ifu): the mitraclip system is indicated for the percutaneous reduction of significant symptomatic mitral regurgitation.All available information was investigated and the reported off-label use in the tricuspid valve likely resulted in failure to advance and tissue damage, and appears to be related to user error.Unchanged tricuspid regurgitation (tr) was a result of procedural conditions.The reported patient effect of tissue damage as listed in the mitraclip system instructions for use (ifu), is a known possible complication associated with mitraclip procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9082800
MDR Text Key159010538
Report Number2024168-2019-11874
Device Sequence Number1
Product Code NKM
UDI-Device Identifier08717648226366
UDI-Public08717648226366
Combination Product (y/n)N
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 10/25/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2020
Device Catalogue NumberCDS0601-XTR
Device Lot Number90329U110
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/28/2019
Initial Date FDA Received09/18/2019
Supplement Dates Manufacturer Received10/16/2019
Supplement Dates FDA Received10/25/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
STEERABLE GUIDE CATHETER; STEERABLE GUIDE CATHETER
Patient Outcome(s) Other;
Patient Age58 YR
Patient Weight53
-
-